vs
Ceribell, Inc.（CBLL）与NATIONAL RESEARCH CORP（NRC）财务数据对比。点击上方公司名可切换其他公司
NATIONAL RESEARCH CORP的季度营收约是Ceribell, Inc.的1.4倍（$35.2M vs $24.8M），NATIONAL RESEARCH CORP净利率更高（5.1% vs -54.6%，领先59.7%），NATIONAL RESEARCH CORP自由现金流更多（$6.1M vs $-11.0M）
Ceribell, Inc.是一家专注于神经诊断领域的医疗科技企业，主打便携式快速脑电图检测设备，可为急症、重症护理场景提供便捷的癫痫发作监测解决方案，核心市场覆盖北美地区，目前正逐步推进全球化业务布局。
NRC Health（原国家研究公司）是一家美国医疗健康企业，1981年成立，总部位于内布拉斯加州林肯市。公司主要在美加两国提供医疗健康相关产品及订阅式解决方案，深耕区域医疗健康服务领域。
CBLL vs NRC — 直观对比
营收规模更大
NRC
是对方的1.4倍
$24.8M
净利率更高
NRC
高出59.7%
-54.6%
自由现金流更多
NRC
多$17.0M
$-11.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $24.8M | $35.2M |
| 净利润 | $-13.5M | $1.8M |
| 毛利率 | 87.3% | — |
| 营业利润率 | -58.9% | 13.3% |
| 净利率 | -54.6% | 5.1% |
| 营收同比 | — | -4.6% |
| 净利润同比 | — | -72.6% |
| 每股收益（稀释后） | $-0.35 | $49.58 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBLLNRC
| Q4 25 | $24.8M | $35.2M | ||
| Q3 25 | $22.6M | $34.6M | ||
| Q2 25 | $21.2M | $34.0M | ||
| Q1 25 | $20.5M | $33.6M | ||
| Q4 24 | — | $36.9M | ||
| Q3 24 | $17.2M | $35.8M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.3M |
净利润CBLLNRC
| Q4 25 | $-13.5M | $1.8M | ||
| Q3 25 | $-13.5M | $4.1M | ||
| Q2 25 | $-13.6M | $-106.0K | ||
| Q1 25 | $-12.8M | $5.8M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | $-10.4M | $5.7M | ||
| Q2 24 | — | $6.2M | ||
| Q1 24 | — | $6.4M |
毛利率CBLLNRC
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率CBLLNRC
| Q4 25 | -58.9% | 13.3% | ||
| Q3 25 | -64.8% | 22.4% | ||
| Q2 25 | -70.5% | 4.7% | ||
| Q1 25 | -69.3% | 25.6% | ||
| Q4 24 | — | 26.0% | ||
| Q3 24 | -57.8% | 22.3% | ||
| Q2 24 | — | 25.3% | ||
| Q1 24 | — | 24.8% |
净利率CBLLNRC
| Q4 25 | -54.6% | 5.1% | ||
| Q3 25 | -59.6% | 11.9% | ||
| Q2 25 | -64.4% | -0.3% | ||
| Q1 25 | -62.4% | 17.2% | ||
| Q4 24 | — | 17.8% | ||
| Q3 24 | -60.6% | 15.9% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 18.0% |
每股收益（稀释后）CBLLNRC
| Q4 25 | $-0.35 | $49.58 | ||
| Q3 25 | $-0.37 | $0.18 | ||
| Q2 25 | $-0.38 | $-0.01 | ||
| Q1 25 | $-0.36 | $0.25 | ||
| Q4 24 | — | $0.27 | ||
| Q3 24 | $-1.85 | $0.24 | ||
| Q2 24 | — | $0.26 | ||
| Q1 24 | — | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $159.3M | $4.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $155.3M | $14.0M |
| 总资产 | $195.8M | $134.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CBLLNRC
| Q4 25 | $159.3M | $4.1M | ||
| Q3 25 | $168.5M | $2.2M | ||
| Q2 25 | $177.4M | $5.3M | ||
| Q1 25 | $182.7M | $2.5M | ||
| Q4 24 | — | $4.2M | ||
| Q3 24 | $14.1M | $3.5M | ||
| Q2 24 | — | $485.0K | ||
| Q1 24 | — | $1.7M |
总债务CBLLNRC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $48.7M | ||
| Q2 24 | — | $33.3M | ||
| Q1 24 | — | $35.2M |
股东权益CBLLNRC
| Q4 25 | $155.3M | $14.0M | ||
| Q3 25 | $164.1M | $14.3M | ||
| Q2 25 | $172.2M | $21.3M | ||
| Q1 25 | $180.9M | $29.7M | ||
| Q4 24 | — | $31.3M | ||
| Q3 24 | $-136.0M | $34.6M | ||
| Q2 24 | — | $40.2M | ||
| Q1 24 | — | $36.9M |
总资产CBLLNRC
| Q4 25 | $195.8M | $134.9M | ||
| Q3 25 | $199.5M | $135.7M | ||
| Q2 25 | $207.7M | $141.4M | ||
| Q1 25 | $213.5M | $135.2M | ||
| Q4 24 | — | $132.5M | ||
| Q3 24 | $47.1M | $131.8M | ||
| Q2 24 | — | $119.1M | ||
| Q1 24 | — | $120.9M |
负债/权益比CBLLNRC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | — | 0.95× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.8M | $7.2M |
| 自由现金流经营现金流 - 资本支出 | $-11.0M | $6.1M |
| 自由现金流率自由现金流/营收 | -44.2% | 17.2% |
| 资本支出强度资本支出/营收 | 0.7% | 3.2% |
| 现金转化率经营现金流/净利润 | — | 3.99× |
| 过去12个月自由现金流最近4个季度 | $-41.6M | $15.7M |
8季度趋势，按日历期对齐
经营现金流CBLLNRC
| Q4 25 | $-10.8M | $7.2M | ||
| Q3 25 | $-11.1M | $13.8M | ||
| Q2 25 | $-7.5M | $-1.1M | ||
| Q1 25 | $-11.4M | $6.6M | ||
| Q4 24 | — | $6.4M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | $6.8M | ||
| Q1 24 | — | $12.0M |
自由现金流CBLLNRC
| Q4 25 | $-11.0M | $6.1M | ||
| Q3 25 | $-11.5M | $10.2M | ||
| Q2 25 | $-7.6M | $-4.1M | ||
| Q1 25 | $-11.6M | $3.7M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | $7.8M | ||
| Q2 24 | — | $1.5M | ||
| Q1 24 | — | $7.9M |
自由现金流率CBLLNRC
| Q4 25 | -44.2% | 17.2% | ||
| Q3 25 | -50.8% | 29.4% | ||
| Q2 25 | -35.9% | -12.2% | ||
| Q1 25 | -56.4% | 10.9% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | — | 22.4% |
资本支出强度CBLLNRC
| Q4 25 | 0.7% | 3.2% | ||
| Q3 25 | 1.6% | 10.4% | ||
| Q2 25 | 0.3% | 8.8% | ||
| Q1 25 | 0.7% | 8.9% | ||
| Q4 24 | — | 12.0% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 15.0% | ||
| Q1 24 | — | 11.7% |
现金转化率CBLLNRC
| Q4 25 | — | 3.99× | ||
| Q3 25 | — | 3.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.15× | ||
| Q4 24 | — | 0.97× | ||
| Q3 24 | — | 1.66× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | — | 1.89× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
NRC
暂无分部数据
